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Abstract
We report a 64 years old gentleman with unresectable right-sided retroperitoneal liposarcoma,
who underwent radiotherapy & subsequently developed chylous ascites. He failed conservative
management of chylous ascites and this was successfully managed with a peritoneovenous shunt.
The pathophysiology and management of post radiational chylous ascites is discussed.
Introduction
Chylous ascites is uncommon; but the incidence has been
increasing. The common causes of chylous ascites are
malignancy and cirrhosis. Radiotherapy is an infrequent
cause of chylous ascites. The management of chylous
ascites comprises treatment of the underlying condition
and peritoneo-venous shunt surgery is reserved for highly
selected cases where the conservative measures fail.
Case presentation
A 64-year-old Singaporean Chinese male was admitted to
the hospital with non-specific abdominal pain. Physical
examination was unremarkable. Computerized tomogra-
phy (CT) scan of the abdomen showed a right sided retro-
peritoneal mass encasing the right renal vein (Figure. 1).
He underwent an exploratory laparotomy. The lesion was
found to be inoperable due to encasement of aorta and
renal vessels and a biopsy was taken. Histology was con-
sistent with a liposarcoma. He underwent radiotherapy to
the lesion. The lesion responded well to radiotherapy and
subsequently decreased in size. However, radiotherapy
was complicated by the development of chylous ascites
(Figure. 2). The presence of chylous ascites was confirmed
by biochemical analysis after abdominal paracentesis. His
ascites failed to resolve with conservative measures requir-
ing fortnightly paracentesis. After six months of repeated
paracentesis, in view of intractable and recurrent ascites,
decision was made to offer a peritoneovenous shunt. A
Denver shunt was performed and his ascites resolved. He
is doing well at 6 months of follow-up without clinical or
radiological evidence of ascites or shunt related complica-
tions.
Discussion
Chylous ascites is the term used to describe milky ascitic
chyle with high fat (triglycerides) contents, usually higher
than 200 mg/dl. Morton first described it in an 18-months
old child in 1619 [1] It is a rare condition with an inci-
dence of 1 in 50,000 to 1 in 100,000 hospital admissions
[2] The incidence has increased, probably due to better
survival of cancer patients and more radical surgeries
being performed commonly.
Multiple etiological factors can give rise to this condition
including primary lymphatic diseases, malignancies, liver
cirrhosis, infection (most commonly tuberculosis), retro-
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peritoneal lymph node dissection, post-radiotherapy of
retroperitoneum, pancreatitis and retroperitoneal fibrosis.
In adults however, chylous ascites is associated most fre-
quently with malignant conditions and more so from
metastatic and disseminated carcinomas. Colonic, pan-
creatic, ovarian, testicular, renal and prostatic carcinomas
are the common primary sites associated with the forma-
tion of chylous ascites due to tumour infiltrating and
blocking the lymphatic vessels. Radiotherapy causes fibro-
sis of lymphatic vessels and ultimately obstruction. The
obstruction of the lymphatic flow from the gut to cysterna
chili causes a high pressure within the lymphatic vessels
with subsequent subserosal leakage and chylous ascites
[3].
Routine laboratory tests may show anemia, lymphocyto-
penia, hypoalbuminemia, raised liver enzymes and
hyponatremia with a normal lipid panel. Confirmation of
diagnosis is achieved by analysis of the ascitic fluid, which
has a milky color with specific gravity raging from 1.010
to 1.054, elevated triglycerides, low cholesterol, high leu-
kocytes count 232 -2560 cells/mm3 and varying levels of
protein contents [4]. In order to ascertain cause the use of
investigations like, CT scan, barium studies, lymphangi-
ogram, lymph node biopsy, bone marrow examination,
intravenous pyelography and even exploratory laparot-
omy have been described [5,6].
Treatment of chylous ascites is directed at the underlying
disease process along with symptomatic relief. Conserva-
tive management with high protein and low-fat diet with
medium chain triglycerides may be successfully tried in
selected cases. Medium chain triglycerides are absorbed
directly into the intestinal cells and transported as free
fatty acids & glycerol directly into the portal vein [5]. This
bypasses the chylomicron to lymphatic transport as occur-
ring with long chain triglycerides. Cirrhotic patients with
chylous ascites are at high risk of developing encephalop-
athy with the above regime and hence salt & fluid restric-
tion along with diuretics is preferable as initial
management. When the above conservative measures fail,
total parenteral nutrition may help by reducing the intes-
tinal lymph flow. However, as in our case, where the lym-
phatic vessels are occluded, the chance of ascites resolving
with conservative means is low and surgery may have to
be considered in selected cases. Surgery to remove the
obstructing lesion, ligating leaking lymphatics or resec-
tion of small bowel segments may either not be possible
or may not yield good results [7]. Lymphangiography or
lymphoscintigraphy may help identify the anatomical site
of leak and provide a roadmap for the surgeon. Lymphatic
microsurgery may be possible in selected cases where
expertise is available. For patients with post radiation chy-
lous ascites when life expectancy is limited because of
underlying pathology a viable option would be regular
abdominal paracentesis or large volume paracentesis
(LVP). This however is associated with complications like,
infection, malnutrition and lymphopenia. For patient
who has intractable and recurrent ascites with a slow
growing tumor and has failed conservative treatment,
peritoneovenous shunting is a viable option. This is less
invasive as compared to laparotomy for ligation of lym-
phatics. It also obviates the needs for repeated paracente-
sis and its associated complications. It benefits the patient
by needing fewer visits to hospital with better life style
and lesser biological/biochemical abnormalities. There
are reports on postoperative chylous ascites being man-
aged by peritoneovenous shunting [8]. The limitations of
this technique are usually seen as shunt occlusion, dis-
seminated intravascular coagulation, subclavian vein/
superior vena cava thrombosis, shunt fracture, infection
and may preclude a liver transplantation in suitable cases.
Preoperative abdominal CT scan showing retroperitoneal  mass encasing the right renal vein (arrow) Figure 1
Preoperative abdominal CT scan showing retroperi-
toneal mass encasing the right renal vein (arrow).
Post radiotherapy CT scan showing reduction in tumour  (arrow) with ascites Figure 2
Post radiotherapy CT scan showing reduction in 
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Also, LVP may be as effective as a peritoneovenous shunt
with no difference in survival [9].
Chylous ascites is a rare form of ascites, but incidence is
increasing. Once diagnosed, paracentensis is indicated for
symptomatic relief. Refractory and recurrent postradia-
tional chylous ascites can be managed by peritoneov-
enous shunting with a good quality of life.
Peritoneovenous shunting should be considered in well-
selected cases when conservative measures fail.
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